Clinical Trials Browser

Phase 2 × Breast Neoplasms × Infliximab × Clear all

NCT00112749 2020-07-31

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Phase 2 Terminated

Breast Carcinoma In Situ, Breast Neoplasms, Fatigue